By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Institute of Medicine today provided a broad set of guidelines for the development of 'omics-based tests, a little more than one year after alleged scientific fraud by a former Duke University researcher was uncovered and shed light on the need for greater oversight.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.